Top insider buys: Feb 5 – Feb 11, 2024

The largest open-market purchases company insiders reported on SEC Form 4 between Feb 5 – Feb 11, 2024.

Week 6, 2024

#	Company	Who bought	Shares	Value	Source
1	LCTX Lineage Cell Therapeutics, Inc.	2 officers/directors Cluster buy Don M. Bailey, BROADWOOD PARTNERS, L.P.	6,826,925	$7.1M	SEC filings
2	WOLF WOLFSPEED, INC.	3 officers/directors Cluster buy Darren R. Jackson, John B. Replogle, Stacy J. Smith	29,450	$767K	SEC filings
3	NYSE:NYCB NEW YORK COMMUNITY BANCORP INC	3 officers/directors Cluster buy Peter Schoels, Lee Matthew Smith, Alessandro DiNello	175,000	$725K	SEC filings
4	ADVM Adverum Biotechnologies, Inc.	2 officers/directors Cluster buy James Paul Scopa, Lupher, Jr. Mark L.	230,000	$311K	SEC filings
5	MKL MARKEL GROUP INC.	2 officers/directors Cluster buy A. Lynne Puckett, Thomas Sinnickson Gayner	172	$243K	SEC filings
6	CIZN CITIZENS HOLDING CO /MS/	2 officers/directors Cluster buy Herbert A. King, Stacy M. Brantley	27,649	$216K	SEC filings
7	OXY OCCIDENTAL PETROLEUM CORP /DE/	10% Owner BERKSHIRE HATHAWAY INC	4,302,324	$245.9M	SEC filings
8	ATXS Astria Therapeutics, Inc.	Director PERCEPTIVE ADVISORS LLC	2,481,350	$30.0M	SEC filings
9	RXO RXO, Inc.	10% Owner MFN Partners, LP	747,424	$15.1M	SEC filings
10	AON Aon plc	Director Lester B. Knight	50,000	$15.1M	SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.